The present invention relates to a telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1H-pyrazole salt derivative of formula (I), the compound (I) itself, and its use as an intermediate in the fabrication of 1-alkyl-4,5-diaminopyrazole salts of general formula (IX). The compounds of formula (IX) can be used as precursor dyes in oxidative hair dye compositions.
R is a mono- or poly-substituted or unsubstituted, straight or branched, saturated or mono- or poly-unsaturated, alkyl group. HZ and HZ′ are mineral or organic acids.
Although scarce in nature, pyrazole, its derivatives and physiologically compatible salts have found uses in many areas, such as pharmaceuticals, agricultural chemicals and hair dyes. Since the discovery of the high potential of these pyrazole derivatives, many publications have been devoted to the synthesis of pyrazoles and related compounds.
In particular, in the oxidative hair dyeing field, 1-substituted-4,5-diaminopyrazole of general formula (II) and salts thereof have shown to be interesting primary intermediates, providing a wide pallet of colour when used with various couplers in the presence of an oxidative dyeing medium.
U.S. Pat. No. 6,452,019 discloses an improved process for the preparation of 4,5-diamino-1-(2′-hydroxyethyl)pyrazole and acid addition salts thereof such as the addition salt from sulfuric acid. The process comprises a combination of steps beginning with an alkyl(alkoxymethylene)cyanoacetate and 2-hydroxyethylhydrazine and the formation of intermediate compounds 5-amino-4-alkoxycarbonyl-1-(2′-hydroxyethyl)pyrazole, 5-amino-4-carboxyl-1-(2′-hydroxyethyl)pyrazole, 5-amino-1-(2′-hydroxyethyl)pyrazole, 5-amino-1-(2′-hydroxyethyl)-4-nitrosopyrazole.
U.S. Pat. No. 5,663,366 describes a process for making 4,5-diaminopyrazole derivative compounds of the formula (D):
wherein R1 and R2 are independently selected from the group consisting of hydrogen, alkyl radicals having one to six carbon atoms and hydroxyalkyl radicals having two to four carbon atoms, provided that R2 may not be tertiary butyl. In said process a) the 3,5-dibromo-4-nitropyrazole (A) is first alkylated in the 1-position by converting with C1- to C6-alkyl halides, C2- to C4-hydroxyalkyl halides or benzyl halides in dimethylformamide (DMF) (method I) or by converting with C1- to C6-alkyl sulfate, C2- to C4-hydroxyalkyl sulfate or benzyl sulfate and caustic solution (method II); b) in a subsequent step, the N-substituted 3,5-dibromo-4-nitropyrazoles of general formula (B) are heated in an aqueous, alcoholic or aqueous-alcoholic solution of C1- to C6-alkyl amine, C2- to C4-hydroxyalkyl amine or benzyl amine or in the corresponding amine itself, as solvent, at a temperature of 60° C. to 80° C.; and c) the compounds of general formula (C) are then hydrogenated using a palladium-on-activated-carbon catalyst with a palladium content of 10 percent by weight to produce compounds of general formula (D).
Hans Höhn describes a synthesis of pyrazole derivatives in the journal “Zeitschrift für Chemie”, 10(10), 386-8; 1970.
The present invention describes a new synthetic route to reach the 1-substituted-4,5-diaminopyrazole of general formula (II) via the key intermediate of the general formula (I).
In particular, the invention provides a sequential one-pot synthesis; with reagents added to a reactor one at a time and without work-up in between. Thus, the major advantage of the process provided by the present invention is to prevent the “workup”; i.e. the several manipulations usually required at the end of a chemical reaction, in order to isolate and purify the intermediates. In addition we can avoid contact with toxic intermediates such as hydrazine. Hydrazine itself and some alkyl- and phenyl-substituted derivatives are officially classified as carcinogens Care IB (former class carc cat 2 under DSD) in Annex VI of the CLP regulation 1272/2008/EC. As a final step any un-reacted hydrazine can be degraded by an excess of the nitroso source present in the reaction mixture into nitrogen gas.
A new process has been developed to synthesize compounds of general formula (II), via a key intermediate of general formula (I), adduct of a telescoping one-pot synthesis. Thus, this allows the production of said compounds of general of formula (II), in a novel, high yield, cost effective and simple way. The telescoping process comprises the steps of:
wherein R is a mono- or poly-substituted or unsubstituted, straight or branched, saturated or mono- or poly-unsaturated, alkyl system,
wherein R is a mono- or poly-substituted or unsubstituted, straight or branched, saturated or mono- or poly-unsaturated, alkyl or heteroalkyl group. More particularly R may be a C1-C11 straight unsubstituted alkyl group, in particular C3 to C7, especially pentyl.
The intermediate compound of formula (I) may be then further treated to form a salt of 4,5-amino-1-n-hexyl-1H-pyrazole of formula (IX). This and other aspects of the invention will now be further discussed in the following non-limiting detailed description.
The different steps involved in the telescoping one-pot synthesis, and leading to the intermediates described will now be detailed. It is to be understood that within the scope of this invention, numerous potentially and actually tautomeric compounds are involved. It is to be understood that when this development refers to a particular structure, all of the reasonable additional tautomeric structures are included. In the art, tautomeric structures are frequently represented by one single structure and the invention follows this general practice.
The term “substituted” refers to a substituent selected from the group of C1-C12 straight or branched carbon chain, as well as halogen, methoxy-, ethoxy-, phosphorus, sulphurous or nitrogen derivated substituents.
It is to be understood that the steps described to make intermediate compound (I) are performed in a sequential one-pot synthesis, with reagents added to a reactor one at a time and without work-up in between. The reaction steps require suitable solvents, as is indicated below.
Non limiting examples of solvents for the step a) comprise pentane, 1,2-dimethoxyethane, cyclopentane, hexane, cyclohexane, benzene, toluene, 1,4-dioxane, chloroform, xylol, methyl-tert-butyl-ether, tert-butanol, dichloromethane, tetrahydrofuran, methyl-tetrahydrofuran, n-butanol, isopropanol, n-propanol, ethanol, methanol, water and mixtures thereof. In a preferred embodiment the solvent is n-propanol. Ionic liquids such as hexafluorophosphate salt of 1-butyl-3-methylimidazolium (BMIM) may also be used as solvents in the different reactions of the invention if applicable.
After the post reaction time, the obtained reaction mixture is immediately converted via step b) below without any work-up to isolate (IV).
R is a mono- or poly-substituted or unsubstituted, straight or branched, saturated or mono- or poly-unsaturated, alkyl or heteroalkyl group. More particularly R may be a C1-C11 straight unsubstituted alkyl group, in particular C3 to C7, especially pentyl. The solvent for step b) may be the same solvent as the one used in step a).
After the second reaction step b) the condensation reaction is performed. The resulting water and the solvent can be removed using conventional methods such as distillation. An extra solvent (toluene for example) can also be added in order to create an azeotrope and improve the removal of water generated during the condensation step b).
Once the conversion of the intermediate (IV) into the intermediate (VI) is completed, the crude solvent free intermediate (VI) present in the reaction vessel is taken directly to the next step.
Non limiting examples of solvents for the step c) comprise 1,2-dimethoxyethane, pentane, cyclopentane, hexane, cyclohexane, benzene, toluene, 1,4-dioxane, diethyl ether, tetrahydrofuran, methyl-tetrahydrofuran, n-butanol, isopropanol, n-propanol, ethanol, methanol, water and mixtures thereof. In a preferred embodiment the solvent is selected from the group consisting of n-butanol, isopropanol, n-propanol, ethanol, methanol, more preferably n-propanol.
Non limiting examples of bases for the step c) comprise sodium methylate (=Sodium methoxide), potassium methylate, lithium methylate, sodium ethylate, potassium ethylate, lithium ethylate, sodium hydroxide, potassium hydroxide, ammonium hydroxide, calcium hydroxide, magnesium hydroxide, barium hydroxide, aluminum hydroxide, ferrous hydroxide or hydroxide, ferric hydroxide or Iron (III) hydroxide Zinc hydroxide, lithium hydroxide, sodium bicarbonate, alkali and earthalkali alcoholates as well as metal hydroxides such as sodium tert-butylate, potassium tert. butylate and mixtures thereof. In a preferred embodiment the preferred bases are selected from the group consisting of sodium methylate, potassium methylate and lithium methylate.
HZ may be chosen from any suitable mineral or organic acids. Non limiting examples of acid HZ for the step d) comprise HCl, CF3COOH, H2SO4, H2SO3, H2CO3, HNO3, CH3COOH, H3PO4, and mixtures thereof. In a preferred embodiment the acid HZ is selected from the group consisting of HCl, H2SO4, H2SO3, more preferably HCl. Acid conditions are believed to be needed to produce the NO+-unit from the nitroso source, as is known in the art.
Non limiting examples of solvents for the step d) comprise 1,2-dimethoxyethane, pentane, cyclopentane, hexane, cyclohexane, benzene, toluene, 1,4-dioxane, diethyl ether, tetrahydrofuran, methyl-tetrahydrofuran, n-butanol, isopropanol, n-propanol, ethanol, methanol, water and mixtures thereof. In a preferred embodiment the solvent is preferably 1,2-dimethoxyethane.
Non limiting examples of nitroso source for the step d) comprise 3-methylbutyl nitrite, nitrosylsulfonic acid, tert-butylnitrite, butylnitrite, nitrite salts such sodium and potassium nitrite and mixtures thereof. In a preferred embodiment the nitroso source is preferably 3-methylbutyl nitrite.
After the last step of the sequence is performed, compound (I) precipitates upon its formation or by triturating the reaction mixture with an adequate solvent. Hence the reaction vessel, at the end of the telescoping one pot synthesis, comprises the un-reacted intermediate of formula (VII) soluble in the solvent and the desired compound of formula (I) as a precipitate. A simple filtration allows isolating the compound of formula (I) as a salt.
Non limiting examples of additional reactions that can be performed with the compound of formula (I) are described below. Indeed, once this sequence of reactions has been achieved successfully, the compound (I) can be converted to its free base, and followed by a conversion again to another salt, if desired.
Non limiting examples of bases for the step e) comprise ammonia, alcoholates such as sodium methylate, potassium methylate, lithium methylate, alcali or earthalkali hydrxydes such as sodium hydroxide, potassium hydroxide, ammonium hydroxide, calcium hydroxide, magnesium hydroxide, barium hydroxide, aluminum hydroxide, ferrous hydroxide or Iron (II) hydroxide, ferric hydroxide or Iron (III) hydroxide, zinc hydroxide, lithium hydroxide, sodium bicarbonate, sodium acetate, potassium acetate, lithium acetate, ammonium acetate, sodium tert-butylate, potassium tert-butylate and mixtures thereof. The preferred base may be ammonia.
Non limiting examples of solvents for the step e) comprise pentane, 1,2-dimethoxyethane, cyclopentane, hexane, cyclohexane, benzene, toluene, 1,4-dioxane, diethyl ether, tetrahydrofuran, methyl-tetrahydrofuran, n-butanol, isopropanol, n-propanol, ethanol, methanol, water and mixtures thereof. In a preferred embodiment the solvent may be a mixture of water and methanol.
Non limiting examples of solvents for the step f) comprise pentane, 1,2-dimethoxyethane, cyclopentane, hexane, cyclohexane, benzene, toluene, 1,4-dioxane, diethyl ether, tetrahydrofuran, methyl-tetrahydrofuran, n-butanol, isopropanol, n-propanol, ethanol, methanol and mixtures thereof. In a preferred embodiment the solvent is selected from the group consisting of water and methanol.
Non limiting examples of a reducing agent for the step f) comprising hydrogen source such as Hydrazine, H2 with a metal catalyst selected from the group consisting of Fe, Pd/C, Pd/(OH)2, Raney-Ni, PtO2 and mixtures thereof. In a preferred embodiment the reducing agent is a mixture of H2 and Pd/C.
HZ′ may be chosen from any suitable organic or mineral acid. Non limiting examples of acid HZ′ for the step f) comprise HCl, H2SO4, 0.5H2SO4, H3PO4, CH3COOH, malic acid and mixtures thereof. In a preferred embodiment the acid is selected from the group consisting of HCl and 0.5H2SO4, more preferably 0.5H2SO4. By 0.5H2SO4 it is meant that about half the molar amount of the pyrazole starting material is reacted to achieve the precipitation of the hemisulfate salt.
In order to reach the compound (IX) an alternative to the steps (e)+(f) describe above would be step (g); i.e. to treat the intermediate (I) via basic treatment. Step (g) is described hereafter:
Non limiting examples of solvents for the step g) comprise pentane, 1,2-dimethoxyethane, cyclopentane, hexane, cyclohexane, benzene, toluene, 1,4-dioxane, diethyl ether, tetrahydrofuran, methyl-tetrahydrofuran, n-butanol, isopropanol, n-propanol, ethanol, methanol and mixtures thereof. In a preferred embodiment the solvent is selected from the group consisting of water and methanol and mixtures thereof.
Non limiting examples of a reducing agent for the reducing step 1) of step f) comprise hydrogen source such as Hydrazine, H2 with a metal catalyst selected from the group consisting of Fe, Pd/C, Pd/(OH)2, Raney-Ni, PtO2 and mixtures thereof. In a preferred embodiment the reducing agent is H2 with a Pd/C catalyst.
Non limiting examples of bases for the reducing step 1) of step g) comprise ammonia, alcoholates such as sodium methylate, potassium methylate, lithium methylate, alcali or earthalkali hydrxydes such as sodium hydroxide, potassium hydroxide, ammonium hydroxide, calcium hydroxide, magnesium hydroxide, barium hydroxide, aluminum hydroxide, ferrous hydroxide or Iron (II) hydroxide, ferric hydroxide or Iron (III) hydroxide, zinc hydroxide, lithium hydroxide, sodium bicarbonate, sodium acetate, potassium acetate, lithium acetate, ammonium acetate, sodium tert-butylate, potassium tert-butylate and mixtures thereof. The preferred base may be selected from sodium acetate, triethylamine or diisopropylethylamine.
Non limiting examples of acid HZ′ for the step 2) of step g) comprise HCl, H2SO4, 0.5H2SO4, H3PO4, CH3COOH, malic acid and mixtures thereof. In a preferred embodiment the acid is selected from the group consisting of HCl, 0.5H2SO4, more preferably 0.5H2SO4.
The following are non-limiting examples of the processes and compositions of the present invention. The examples are given solely for the purpose of illustration and are not to be construed as limitations of the present invention, as many variations thereof are possible without departing from the spirit and scope of the invention, which would be recognized by one of ordinary skill in the art. All concentrations are listed as weight percent, unless otherwise specified.
The process described above can be utilized to synthesize 5-amino-4-nitroso-1-n-hexyl-pyrazole-HCl formula (I-a). In one The telescoping process comprises the steps of:
Non-limiting examples of subsequent reactions on compound (I-a) can be:
As an alternative to the subsequent reactions (e)+(f), the reaction on compound (I-a) can be:
These examples will now be detailed hereinbelow.
The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm.”
Any embodiment disclosed as “preferred” is not intended as limiting the scope of protection, unless expressly mentioned otherwise.
Every document cited herein, including any cross referenced or related patent or application, is hereby incorporated herein by reference in its entirety unless expressly excluded or otherwise limited. The citation of any document is not an admission that it is prior art with respect to any invention disclosed or claimed herein or that it alone, or in any combination with any other reference or references, teaches, suggests or discloses any such invention. Further, to the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.
While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Number | Date | Country | Kind |
---|---|---|---|
12155707 | Feb 2012 | EP | regional |
Number | Name | Date | Kind |
---|---|---|---|
3709437 | Wright | Jan 1973 | A |
3937364 | Wright | Feb 1976 | A |
4022351 | Wright | May 1977 | A |
4147306 | Bennett | Apr 1979 | A |
4184615 | Wright | Jan 1980 | A |
4615467 | Grogan | Oct 1986 | A |
5061289 | Clausen | Oct 1991 | A |
5380340 | Neunhoeffer | Jan 1995 | A |
5430159 | Neunhoeffer | Jul 1995 | A |
5443569 | Uehira | Aug 1995 | A |
5534267 | Neunhoeffer | Jul 1996 | A |
5663366 | Neunhoeffer | Sep 1997 | A |
5718731 | Loewe | Feb 1998 | A |
5752983 | Audousset | May 1998 | A |
5766576 | Loewe | Jun 1998 | A |
5769902 | Samain | Jun 1998 | A |
5785717 | Maubru | Jul 1998 | A |
5865855 | Doehling | Feb 1999 | A |
5931973 | Malle | Aug 1999 | A |
6053364 | Van der Heijden | Apr 2000 | A |
6090162 | Maubru | Jul 2000 | A |
6099592 | Vidal | Aug 2000 | A |
6118008 | Malle | Sep 2000 | A |
6338741 | Vidal | Jan 2002 | B1 |
6379396 | Audousset | Apr 2002 | B1 |
6452019 | Cook | Sep 2002 | B1 |
6503282 | Braun | Jan 2003 | B1 |
6554871 | Braun | Apr 2003 | B2 |
6600050 | Chassot | Jul 2003 | B2 |
6604693 | Santagiuliana | Aug 2003 | B2 |
6645258 | Vidal | Nov 2003 | B2 |
6660046 | Terranova | Dec 2003 | B1 |
6716257 | Goettel | Apr 2004 | B2 |
6740127 | Friess | May 2004 | B2 |
6780203 | Maubru | Aug 2004 | B1 |
6793687 | Javet | Sep 2004 | B2 |
6855827 | Vidal | Feb 2005 | B2 |
6887280 | Lim | May 2005 | B2 |
6905522 | Kravtchenko | Jun 2005 | B2 |
6939382 | Fessmann | Sep 2005 | B2 |
7004979 | Kravtchenko | Feb 2006 | B2 |
7014663 | Fessmann | Mar 2006 | B2 |
7018426 | Javet | Mar 2006 | B2 |
7056354 | Fessmann | Jun 2006 | B2 |
7070629 | Kravtchenko | Jul 2006 | B2 |
7091350 | Fessmann | Aug 2006 | B2 |
7153330 | Cotteret | Dec 2006 | B2 |
7195649 | Goettel | Mar 2007 | B2 |
7250063 | Fessmann | Jul 2007 | B2 |
7285136 | Fessmann | Oct 2007 | B2 |
7285137 | Vidal | Oct 2007 | B2 |
7300469 | Fessmann | Nov 2007 | B2 |
7927381 | Hercouet | Apr 2011 | B2 |
20030000027 | Hoeffkes | Jan 2003 | A1 |
20030106167 | Rose | Jun 2003 | A1 |
20040216242 | Kravtchenko | Nov 2004 | A1 |
20060183781 | Goettel | Aug 2006 | A1 |
20060219738 | Izuka | Oct 2006 | A1 |
20070033742 | Goettel | Feb 2007 | A1 |
20070037987 | Chamberlin | Feb 2007 | A1 |
20070050924 | Cotteret | Mar 2007 | A1 |
20080141468 | Cotteret | Jun 2008 | A1 |
20130212810 | Geibel | Aug 2013 | A1 |
Number | Date | Country |
---|---|---|
2646867 | Mar 2009 | CA |
3432983 | Apr 1985 | DE |
19619112 | Nov 1997 | DE |
10032135 | Jan 2002 | DE |
20017640 | Feb 2002 | DE |
0663204 | Jul 1995 | EP |
0873109 | Feb 2004 | EP |
1405628 | Apr 2004 | EP |
1488783 | Nov 2006 | EP |
1787631 | May 2007 | EP |
1787632 | May 2007 | EP |
1795178 | Jun 2007 | EP |
1795179 | Jun 2007 | EP |
1797863 | Jun 2007 | EP |
1985282 | Oct 2008 | EP |
2604622 | Dec 1990 | FR |
2831055 | May 2004 | FR |
WO0147475 | Jul 2001 | WO |
WO0209662 | Feb 2002 | WO |
WO02055500 | Jul 2002 | WO |
WO02083090 | Oct 2002 | WO |
WO2004024109 | Mar 2004 | WO |
WO2005023209 | Mar 2005 | WO |
WO2008047210 | Apr 2008 | WO |
WO2009077390 | Jun 2009 | WO |
Entry |
---|
[Database Registry Chemical Abstracts Service, Columbus, Ohio, Accession No. RN 1248707-36-9, Entered STN: Oct. 29, 2010]. |
Hans Höhn; XP-002681362; journal “Zeitschrift für Chemie”, 10(10), 386-8; 1970. |
Number | Date | Country | |
---|---|---|---|
20130217891 A1 | Aug 2013 | US |